Medication info
Ravetra Tablet 20 mg (Rabeprazole Sodium)

Ravetra Tablet 20 mg (Rabeprazole Sodium)

Prescription medicationTabletOral
Ingredient · strength
Rabeprazole Sodium›20mg / 1 tablet
Manufacturer / importer
YouYoung Pharmaceutical Co., Ltd.
Appearance
Light yellow, round, enteric-coated tablet
Packaging
28 tablets (14 tablets/PTP packaging × 2) (for export), 28 tablets (14 tablets/AluAlu packaging x 2)
Approval status
Active

MFDS item code 200703185 · Notified 2007.03.16 · Insurance code 648200240

Summary

Main use
Treatment of gastroesophageal reflux disease, ulcers (including Helicobacter pylori eradication), and Zollinger-Ellison syndrome
Who takes it
Adults · Children
Adult dose
Gastric ulcer, duodenal ulcer The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI, proton pump inhibitor), an additional 8 weeks of oral treatment with 10 mg or 20 mg twice daily may be given. However, the 20 mg twice-daily dose is for patients with confirmed severe mucosal damage only. Relief of symptoms of gastroesophageal reflux disease Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms resolve, an on-demand regimen of 10 mg once daily may be used as needed to control subsequent symptoms. Long-term maintenance therapy for gastroesophageal reflux disease Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication Patients with Helicobacter pylori infection should receive eradication therapy. It is recommended that this drug 20 mg be administered in combination with clarithromycin 500 mg and amoxicillin 1 g twice daily for 7 days. Zollinger-Ellison syndrome The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted up to 120 mg daily according to each patient's needs. Doses up to 100 mg may be administered once daily, while the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have experience receiving this drug for up to 1 year. Patients with hepatic impairment Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. Older adults Administer with caution, as liver function is often reduced.
Child dose
Safety in children has not been established.

Ingredients

Manufacturer
YouYoung Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastroesophageal reflux disease, ulcers (including Helicobacter pylori eradication), and Zollinger-Ellison syndrome

  • Gastric ulcer
  • duodenal ulcer
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
  • gastroesophageal reflux disease
  • gastrointestinal ulcers infected with Helicobacter pylori
  • Zollinger-Ellison syndrome
View approved original text

This medication is effective in treating gastric and duodenal ulcers, and is used to relieve symptoms of erosive or ulcerative esophagitis caused by gastroesophageal reflux disease. It also helps in long-term maintenance therapy of gastroesophageal reflux disease, and increases the therapeutic effect when used in combination with antibiotics for patients with gastrointestinal ulcers infected with Helicobacter pylori. It is also used in the treatment of Zollinger-Ellison syndrome by inhibiting gastric acid secretion and improving symptoms. Overall, this medication is used in the treatment and symptom relief of various gastrointestinal ulcers and gastroesophageal-related diseases.

How to take

Adult dose

Gastric ulcer, duodenal ulcer The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI, proton pump inhibitor), an additional 8 weeks of oral treatment with 10 mg or 20 mg twice daily may be given. However, the 20 mg twice-daily dose is for patients with confirmed severe mucosal damage only. Relief of symptoms of gastroesophageal reflux disease Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms resolve, an on-demand regimen of 10 mg once daily may be used as needed to control subsequent symptoms. Long-term maintenance therapy for gastroesophageal reflux disease Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication Patients with Helicobacter pylori infection should receive eradication therapy. It is recommended that this drug 20 mg be administered in combination with clarithromycin 500 mg and amoxicillin 1 g twice daily for 7 days. Zollinger-Ellison syndrome The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted up to 120 mg daily according to each patient's needs. Doses up to 100 mg may be administered once daily, while the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have experience receiving this drug for up to 1 year. Patients with hepatic impairment Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. Older adults Administer with caution, as liver function is often reduced.

Child dose

Safety in children has not been established.

Precautions

This medication should not be used in patients with hypersensitivity to certain ingredients or those who have experienced such reactions in the past. In addition, patients taking certain antibiotics or antivirals, and pregnant or nursing women, should not use this medication. Patients with impaired liver function or the elderly should use this medication cautiously, and caution is also needed in those with a history of hypersensitivity to the drug. This medication contains a dye called Yellow No. 4, so patients allergic to it should be careful. During administration, hypersensitivity reactions such as skin rash and itching may occur, and if such symptoms appear, the medication should be discontinued immediately. Blood tests may show fluctuations in red or white blood cell counts, so regular blood tests are recommended. Symptoms of liver dysfunction may also appear, so liver function tests should be conducted periodically. There have been reports of cardiac-related abnormal symptoms, gastrointestinal problems, neurological symptoms, respiratory and musculoskeletal issues, so caution is needed. Severe reactions may occur on the skin, so if there are skin rashes, hives, or hair loss, the patient should consult a doctor immediately. Abnormalities may occur in the eyes or ears, so any changes in vision or hearing should be reported. There have also been reports of urinary tract abnormalities, and caution should be exercised if difficulties in urination or hematuria appear. Long-term use of this medication may increase the risk of fractures related to osteoporosis, so bone health should be managed when used for extended periods. Hypomagnesemia may rarely occur, so magnesium levels should be checked regularly when taking for long durations or in combination with certain drugs. This medication inhibits gastric acid secretion, which may slightly increase the risk of bacterial infections in the stomach, so if diarrhea persists, the patient should notify a doctor immediately. Caution is needed as there is a risk of accidents due to drowsiness while driving or operating machinery. This medication may interact with other drugs, so especially when used in combination with antibiotics, antivirals, anticoagulants, etc., consultation with medical staff is required. It is safest to avoid using this medication during pregnancy or nursing. The elderly may experience adverse reactions due to decreased liver function, so if symptoms emerge, the medication should be stopped immediately and a doctor consulted. The safety in children has not been established, so use is not recommended. There is no specific antidote for overdose, and treatment and supportive therapy according to symptoms are necessary. This medication should be swallowed whole and not chewed or crushed. Keep out of reach of children, and it is advisable not to transfer to other containers. During the use of this medication, symptoms of autoimmune diseases such as cutaneous lupus or systemic lupus may appear, so if there are suspicious symptoms, the healthcare provider should be notified immediately. Additionally, this medication may affect the results of certain neuroendocrine tumor tests, so consult medical staff before the tests. Symptoms of kidney abnormalities such as acute interstitial nephritis may occur, so if symptoms like fatigue, nausea, or loss of appetite appear, notify a doctor immediately.

Side effects

Rash, urticaria, itching, erythrocytopenia, leukopenia, leukocytosis, eosinophilia, neutrophilia, lymphocytopenia, anemia, petechiae, lymphadenopathy, hypochromic anemia, pancytopenia, agranulocytosis, thrombocytopenia, hemolytic anemia, elevated ALT, elevated AST, elevated ALP, elevated γ-GTP, elevated LDH, elevated total bilirubin, fulminant hepatitis, liver dysfunction, jaundice, hypertension, myocardial infarction, abnormal electrocardiogram, migraine, syncope, angina pectoris, heart block, palpitations, bradycardia, tachycardia, pulmonary embolism, ventricular tachycardia, thrombophlebitis, vasodilation, prolonged QTc, ventricular fibrillation, diarrhea, constipation, abdominal pain, abdominal bloating, dyspepsia, belching, nausea, rectal bleeding, blood in stool, anorexia, cholelithiasis, oral ulcers, dysphagia, gingivitis, cholecystitis, increased appetite, abnormal stool, colitis, esophagitis, glossitis, pancreatitis, proctitis, dry mouth, vomiting, lower abdominal pain, gastric body, gastritis, stomatitis, taste disturbance, hemorrhagic diarrhea, cholangitis, duodenitis, gastrointestinal bleeding, hepatic encephalopathy, hepatitis, liver cancer, hepatic steatosis, salivary gland enlargement, thirst, headache, insomnia, anxiety, dizziness, convulsions, abnormal dreams, decreased libido, neuropathy, sensory disturbance, tremors, weakness, hyperesthesia, drowsiness, vertigo, depression, restlessness, amnesia, confusion, extrapyramidal syndrome, hypervolemia, weakness of limbs, paresthesia, decreased grip strength, language confusion, staggering, delirium, disorientation, hypersomnia, cough, pharyngitis, rhinitis, dyspnea, asthma, epistaxis, laryngitis, hiccups, hyperventilation, bronchitis, sinusitis, apnea, respiratory depression, interstitial pneumonia, myalgia, back pain, arthritis, leg cramps, bone pain, arthrosis, bursitis, hypertonia, neuralgia, single contraction, sweating, alopecia, dry skin, herpes zoster, psoriasis, skin color changes, toxic epidermal necrolysis, mucous membrane syndrome, erythema multiforme, cataracts, amblyopia, glaucoma, dry eyes, abnormal vision, tinnitus, otitis media, corneal opacity, blurriness, double vision, hearing loss, eye pain, retinal degeneration, strabismus, proteinuria, cystitis, frequent urination, dysmenorrhea, dysuria, nephrolithiasis, uterine bleeding, polyuria, breast enlargement, hematuria, erectile dysfunction, vaginal discharge, menorrhagia, orchitis, urinary incontinence, interstitial nephritis, edema, elevated total cholesterol, elevated triglycerides, elevated BUN, elevated serum thyroid-stimulating hormone, chest pain, chills, fever, urinary tract infection, erythema, lethargy, weight gain, visual disturbances, anorexia, cervical rigidity, phototoxic reaction, hangover effect, weight loss, gout, anaphylaxis, shock, hepatitis, jaundice, hepatic encephalopathy, sudden death, coma, hyperammonemia, rhabdomyolysis, delirium, angioedema, hypomagnesemia, thrombocytopenia, neutropenia, vesicular skin rash, systemic allergic reaction, arthralgia, interstitial nephritis, gynecomastia, elevated thyroid-stimulating hormone, visual impairment, skin lupus erythematosus, systemic lupus erythematosus, halitosis, dry mouth, increased intraocular pressure, palpitations, confusion, tingling of hands and feet, facial edema, flushing

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius. Doing so will help maintain the effectiveness of the medication for a longer period.

Appearance and packaging

Appearance

Light yellow, round, enteric-coated tablet

Package unit

28 tablets (14 tablets/PTP packaging × 2) (for export), 28 tablets (14 tablets/AluAlu packaging x 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.